Translating evidence into practice: The importance of continuing local bacterial surveillance even when national data are available

Infection Control and Hospital Epidemiology

Volumn 30, Issue 11, 2009, Pages 1128-1130

  Darveau, Martin ^a,b   Ducharme Désilets, Catherine ^a,b   Archambault, Patrick ^a,b   Marcoux, Diane ^a,b  

^a Hotel Dieu de Levis Hospital   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL FLORA; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANADA; CRITICALLY ILL PATIENT; DRUG CHOICE; ENTEROBACTER CLOACAE; ENTEROCOCCUS; ESCHERICHIA COLI; EVIDENCE BASED PRACTICE; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; LETTER; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PROGNOSIS; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; BACTERIUM; CLASSIFICATION; DRUG EFFECT; HEALTH SURVEY; HETEROZYGOTE; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; PREVALENCE; STAPHYLOCOCCUS INFECTION; STATISTICS;

BACTERIA; BACTERIAL INFECTIONS; CANADA; CARRIER STATE; DRUG RESISTANCE, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; POPULATION SURVEILLANCE; PREVALENCE; QUEBEC; STAPHYLOCOCCAL INFECTIONS;

EID: 71949100565     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/606041     Document Type: Letter

References (8)

1. Kollef MH. Bench-to-bedside review: antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit. Crit Care 2005; 9:459-464.
2. Garnacho-Montero J, Ortiz-Leyba C, Herrera-Melero I, et al. Mortality and morbidity attributable to inadequate empirical antimicrobial therapy in patients admitted to the ICU with sepsis: a matched cohort study. J Antimicrob Chemother 2008; 61:436-441.
3. Leone M, Bourgoin A, Cambon S, Dubuc M, Albanese J, Martin C. Empirical antimicrobial therapy of septic shock patients: adequacy and impact on the outcome. Crit Care Med 2003;31(2):462-467.
4. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34:1589-1596.
5. Zhanel GG, DeCorby M, Laing N, et al. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Antimicrob Agents Chemother 2008; 52:1430-1437.
6. Masterton R. The importance and future of antimicrobial surveillance studies. Clin Infect Dis 2008; 47(Suppl 1):S21-S31.
7. Graham ID, Tetroe J. Some theoretical underpinnings of knowledge translation. Acad Emerg Med 2007; 14:936-941.
8. Pagani L, Falciani M, Aschbacher R. Use of microbiologic findings to manage antimicrobials in the intensive care unit. Infect Control Hosp Epidemiol 2009; 30:309-311